Protein profile

KP13_04562

putative oxidoreductase

Genome: KpKP13

Gene: AHE44437.1 Structure source: AlphaFold + ColabFold UniProt A0A060VHP0
Amino acids 331
Annotations 3
Features 26
PDB binders 2
Druggability 0.981

Overview

Basic information about this protein and its source genome.

Accession
KP13_04562
Gene
AHE44437.1
Status
annotated
Amino acids
331
Structure source
AlphaFold + ColabFold

Target profile

Computed evidence for target prioritization.

Human off-target
hit
Human identity (%)
36.364
Human E-value
2.97e-12
Gut microbiome off-target
hit
Essential (DEG)
N
DEG identity (%)
0.0
Localization
Cytoplasmic
ColabFold pLDDT
95.44

Selected Druggability evidence

AlphaFold / UniProt model

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.981
Structure A0A060VHP0
Pocket Pocket 1
P2Rank 0.982
Structure A0A060VHP0
Pocket Pocket 1
ColabFold model
FPocket 0.993 · Pocket 1
P2Rank 0.979 · Pocket 1
Core conservation Accessory gene
Roary accessory
CoreCruncher accessory
Gut microbiome 26 / 4744 genomes with a hit
Normalized 0.005

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 2 GO

Enzyme Commission (EC)

1

Gene Ontology (GO)

2
  • GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
  • GO:0016020 A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it.

Sequence Features

Domain/signature hits from InterPro and related databases.

26 records
Show feature table
Start End DB Term Name
307 324 TMHMM TMhelix Region of a membrane-bound protein predicted to be embedded in the membrane.
2 183 SMART SM00822 This enzymatic domain is part of bacterial polyketide synthases and catalyses the first step in the reductive modification of the beta-carbonyl centres in the growing polyketide chain. It uses NADPH to reduce the keto group to a hydroxy group.
262 293 MobiDBLite mobidb-lite consensus disorder prediction
1 302 Phobius NON_CYTOPLASMIC_DOMAIN Region of a membrane-bound protein predicted to be outside the membrane, in the extracellular region.
2 263 Gene3D G3DSA:3.40.50.720 -
130 138 PRINTS PR00080 Short-chain dehydrogenase/reductase (SDR) superfamily signature
130 138 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
150 169 PRINTS PR00080 Short-chain dehydrogenase/reductase (SDR) superfamily signature
150 169 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
77 88 PRINTS PR00080 Short-chain dehydrogenase/reductase (SDR) superfamily signature
77 88 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
325 331 Phobius CYTOPLASMIC_DOMAIN Region of a membrane-bound protein predicted to be outside the membrane, in the cytoplasm.
3 189 Pfam PF00106 short chain dehydrogenase
3 189 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
137 165 ProSitePatterns PS00061 Short-chain dehydrogenases/reductases family signature.
137 165 InterPro IPR020904 Short-chain dehydrogenase/reductase, conserved site
3 256 PANTHER PTHR44196 DEHYDROGENASE/REDUCTASE SDR FAMILY MEMBER 7B
3 255 SUPERFAMILY SSF51735 NAD(P)-binding Rossmann-fold domains
3 255 InterPro IPR036291 NAD(P)-binding domain superfamily
303 324 Phobius TRANSMEMBRANE Region of a membrane-bound protein predicted to be embedded in the membrane.
3 20 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
3 20 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
150 169 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
77 88 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
124 140 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
124 140 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 2

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold AF_A0A060VHP0
AlphaFold full sequence Viewing
ColabFold KP13_04562
ColabFold full sequence Loaded
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
1 0.981
3 0.557

Pockets (P2RANK)

Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).

P2RANK Sticks Spheres Surfaces Score Probability Labels Zoom Positions
1 40.18 0.963

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

152 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
AOI Q8NBQ5 290.4 Da LogP 3.96 TPSA 37.3 ✓ Ro5 ✓ Clean C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4(…
BIO Q8KES3 237.2 Da LogP -1.29 TPSA 138.0 ✓ Ro5 ✓ Clean C[C@H]([C@H](c1cnc2c(n1)C(=O)NC(=N2)N)O)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.